/https://tf-cmsv2-smithsonianmag-media.s3.amazonaws.com/filer_public/c1/a2/c1a2a82f-5e62-4728-a670-4816f111957b/beta-amyloid_plaques_and_tau_in_the_brain_38686503251.png)
❤️ Health
July 23, 2026 at 07:32 PM
Experimental Alzheimer's Drug That Fights a Tough-to-Target Protein Shows Promise at Slowing Cognitive Decline in a Clinical Trial
Source:
Smithsonian Magazine
An experimental Alzheimer's drug targeting the tau protein shows promise in clinical trials, potentially slowing cognitive decline and offering a new approach beyond existing treatments.
Alzheimer's
drug
cognitive decline
medical breakthrough
clinical trial